ClinicalTrials.Veeva

Menu

The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation

Seoul National University logo

Seoul National University

Status

Completed

Conditions

ICH
Brain Tumor
AVM

Treatments

Drug: remifentanil

Study type

Interventional

Funder types

Other

Identifiers

NCT01489137
JHBahk_fixation_remifentanil

Details and patient eligibility

About

The purpose of this study is to estimate the EC90 of remifentanil blunting hemodynamic changes to head fixation in the patients undergoing neurosurgery.

Enrollment

50 patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing neurosurgery that require head fixation with mayfield head holder
  • patients who agree to our study

Exclusion criteria

  • patients who don't agree to our study
  • BMI<16.0 or BMI>30
  • cardiovascular disease, pulmonary disease, renal disease
  • alcoholic abuser or drug abuser
  • patients who takes any drug having an influence on cardiovascular system or sympathetic nervous system
  • any use of local anesthetics or drugs which have an influence on cardiovascular system from beginning of induction to peri-fixation period

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

neurosurgery with fixation
Experimental group
Treatment:
Drug: remifentanil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems